MedTrace Logo

Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT

NCT02379338 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2025-09-02

No results posted yet for this study

Summary

In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer \[18F\]Fluortriopride (\[18F\]FTP).

Conditions

  • Healthy

Interventions

DRUG

[18F]Fluortriopride

All subjects will receive a \[18F\]Fluortriopride PET/CT scan

Sponsors & Collaborators

Principal Investigators

  • Jacob Dubroff, MD, PhD · Hospital of University of Pennsylvania

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379338 on ClinicalTrials.gov